The European Society for Medical Oncology (ESMO) Annual Congress is the largest, most preeminent cancer conference outside the US, drawing over 30,000 participants from across the world each year. Oncology experts from Lumanity joined the gathering in Berlin to learn and engage with the latest research and with colleagues across the biopharma industry. We are pleased to share selected highlights and insights contributed by members of our team.

Download the full perspective

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Sign me up to receive regular insights from Lumanity
By selecting this box, I consent to receive Lumanity marketing communications by email.